Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 35 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/9/2004


1.		Phase I/II Pilot Study of Interleukin-12 in Patients With AIDS-Associated Kaposi's Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				NCI-96-C-0113F NCI-MB-386, NCI-T96-0029N, T96-0029, NCT00019188

Last Modified: 2/1/2002


2.		Phase I/II Study of Immunization with MAGE-3 or Melan-A Peptide-Pulsed Autologous Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 in Patients with Metastatic Melanoma (Summary Last Modified 02/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				Not specified				NCI				UCCRC-9018 UCCRC-8381, NCI-G97-1162, NCT00002952

Last Modified: 8/28/2006 First Published: 11/24/2002


3.		Phase I/II Study of Interleukin-12 (IL-12) Followed By IL-12 and Interleukin-2 in Patients With Mycosis Fungoides

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				UPCC-10401 NCI-1831, 1831, NCT00052377

Last Modified: 9/1/1997


4.		Phase II Study of Interleukin-12 vs Interferon Alfa-2a in Previously Untreated Patients with Locally Advanced or Metastatic Renal Cell Carcinoma (Summary Last Modified 09/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				MSKCC-97002 ROCHE-BO15469, NCI-G97-1236

Last Modified: 6/25/2007


5.		Phase II Pilot Study of HER2-Neu Peptide Vaccine in Patients with Recurrent Metastatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-97-C-0118 NCI-T97-0009, T97-0009

Last Modified: 7/9/2004 First Published: 7/1/1997


6.		Phase II Study of Interleukin-12 (IL-12) in Patients With Advanced, Recurrent, or Inoperable Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ECOG-E1E96 E1E96, NCT00003017

Last Modified: 5/14/2007 First Published: 1/1/1998


7.		Phase II Randomized Study of Interleukin-12 in Patients With Plateau Phase Multiple Myeloma (Summary Last Modified 10/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				E-1A96 NCT00003149, E1A96

Last Modified: 11/2/2005 First Published: 1/1/1998


8.		Phase II Study of Recombinant Human Interleukin-12 in Recurrent, Refractory, and Metastatic Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				GOG-170B

Last Modified: 2/10/2004 First Published: 3/1/1998


9.		Phase II Study of Interleukin-12 in Patients with Previously Treated Non-Hodgkin's Lymphoma and Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				MDA-DM-97073 NCI-T97-0050, NCT00003210, T97-0050

Last Modified: 5/21/2007 First Published: 7/1/1998


10.		Phase II Randomized Study of a Vaccine Combining Tyrosinase and gp100 Peptides Emulsified with Montanide ISA-51 With or Without Interleukin-12 for Patients with Resected Stage III or IV Melanoma (Summary Last Modified 03/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				LAC-USC-10M973 NCI-G98-1432, NCI-T97-0099, NCT00003339, T97-0099

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute